Research Leader, Science and Emerging Technology group, RAND Europe

Richard Milne is a research leader at RAND Europe in the Science and Emerging Technology group. He is an experienced social scientist with expertise in qualitative and quantitative research methods, bioethics, and public engagement. His work has focused on biotechnology, genomics, neurotechnology, and dementia. Particular questions of interest relate to public trust, the governance of genomic and health data, and how to embed ethics and public engagement in innovation processes.

Before joining RAND, Milne led a team conducting social science and bioethics research at the Wellcome Sanger Institute, was Deputy Director and Research Lead at the Kavli Centre for Ethics, Science, and the Public at the University of Cambridge and an associate faculty member of the Cambridge Centre for AI in Medicine. He led research at Sanger, Cambridge, Sheffield, and the PHG Foundation on projects funded by Wellcome, ARIA, NIHR, the Innovative Medicines Initiative and the Kavli Foundation. He has held advisory roles in national and international initiatives related to health and administrative data sharing, dementia research, genomics, engineering biology, and geoengineering and has been a member of steering or delivery groups for public dialogues for DARE-UK, Sciencewise, Genomics England, Our Future Health, and the University of Cambridge’s AI mission, Engineering Biology research centre, and Public Health research initiative.

Milne received his Ph.D. in science and technology studies from the University College London.